Table 2.
Clinical markers of HIV infected children in Addis Ababa, Ethiopia, [N = 390] April 2008
Variable | Frequency(percentage) | p-value | |
adherent | Non-adherent | ||
WHO Clinical stage of HIV disease | 0.226 | ||
Stage I | 14(4.13) | 1(2) | |
Stage II | 102(30.1) | 9(17.6) | |
Stage III | 163(48.07) | 30(58.8) | |
Stage IV | 60(17.7) | 11(21.6) | |
CD4 counts at start of treatment | 0.377 | ||
<200 | 164(48.4) | 30(58.8) | |
200–499 | 131(38.6) | 16(31.4) | |
> = 500 | 44(13) | 5(9.8) | |
Current CD4 count | 0.073 | ||
<200 | 45(13.3) | 12(23.5) | |
200–499 | 119(35.1) | 20(39.2) | |
> = 500 | 175(51.6) | 19(37.3) | |
Regimen recommended | 0.105 | ||
4a = d4T/3TC/NVP | 103(30.4) | 16(31.4) | |
4b = d4T/3TC/EFV | 53(15.6) | 9(17.6) | |
4c = AZT/3TC/NVP | 97(28.6) | 7(13.7) | |
4d = AZT/3TC/EFV | 86(25.4) | 19(37.3) |
d4T = Stavudine, 3TC = Lamivudine, NVP = Nevirapine, AZT = Zidovudine, EFV = Efavirenz